Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of New Methodologies and Innovative Tools for the diagnoSi and Therapeutic Treatment of uMAni Epithelial Tumors

NCT06939049 is registered in ClinicalTrials.gov with ASL Lecce as lead sponsor.

NCT NCT06939049
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06939049 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of New Methodologies and Innovative Tools for the diagnoSi and Therapeutic Treatment of uMAni Epithelial Tumors
Lead sponsor
ASL Lecce
Phase
Observational
Overall status
Completed
Start date
May 2, 2017
Completion date
March 31, 2026
Enrollment
250 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer risk, cancer risk, lung cancer (nsclc)